Penn Medicine been nationally recognized as an approved NPF Center by the National Pancreas Foundation. NPF Centers are awarded after a rigorous audit review to determine that an institutions focus is on multidisciplinary treatment of pancreatitis, treating the "whole patient" with a focus on the best possible outcomes and an improved quality of life.
"This designation is certainly a validation of our entire team's delivery of excellent patient care," says Dr. Nuzhat Ahmad, MD, Vice Chief of Gastroenterology, Penn Medicine, Co-Director of the PENN Pancreatic Cyst Program, and lead for the Pancreas Program at the Hospital of University of Pennsylvania.
Penn Medicine's Chief of Gastrointestinal Surgery, Charles Vollmer, MD, has a 20 year relationship with the NPF and now sits on their Board of Directors, where he is currently responsible for developing their global expansion strategy mission.
National Pancreas Foundation Centers of Excellence Designation
An approved NPF Center meets an extensive process and meets criteria developed by a task force made up of invited subject matter experts and patient advocates. The criteria includes having the required team of expert physician specialties such as gastroenterologists, pancreas surgeons, and interventional radiologists, along with more patient focused programs such as a pain management service, psychosocial support and more.
"We are honored that Penn Medicine been designated as NPF Center for treatment of pancreatitis," said Dr. Jorge Marrero, MD, MS Chief of the Division of Gastroenterology and Hepatology at Penn Medicine. "Having the NPF Center designation will continue to differentiate Penn Medicine as an organization whose focus is on providing the best and most innovative care possible."
